DEA schedule
Is tazarotene a controlled substance?
Federal schedule for tazarotene from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Tazarotene is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tazarotene is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted tazarotene?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 22 prescription listings from 10 labelers, none with a DEA schedule |
| DEA controlled substances list | tazarotene is not on the list |
Tazarotene NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0187-2098 | Arazlo | lotion | .45 mg/g | Bausch Health US, LLC | None |
| 51862-295 | FABIOR | aerosol, foam | 1 mg/g | Mayne Pharma | None |
| 16110-915 | TAZORAC | cream | .05 mg/g | Almirall, LLC | None |
| 16110-916 | TAZORAC | cream | .1 mg/g | Almirall, LLC | None |
| 16110-833 | Tazorac | gel | .5 mg/g | Almirall, LLC | None |
| 16110-042 | Tazorac | gel | 1 mg/g | Almirall, LLC | None |
| 68308-685 | tazarotene | aerosol, foam | 1 mg/g | Mayne Pharma Inc. | None |
| 0713-0765 | Tazarotene | cream | .5 mg/g | Cosette Pharmaceuticals, Inc. | None |
| 45802-706 | TAZAROTENE | cream | .5 mg/g | Padagis Israel Pharmaceuticals Ltd | None |
| 72162-2420 | TAZAROTENE | cream | .5 mg/g | Bryant Ranch Prepack | None |
| 0713-0670 | Tazarotene | cream | 1 mg/g | Cosette Pharmaceuticals, Inc. | None |
| 51672-1373 | Tazarotene | cream | 1 mg/g | Sun Pharmaceutical Industries, Inc. | None |
| 51672-1374 | Tazarotene | cream | 1 mg/g | Sun Pharmaceutical Industries, Inc. | None |
| 68308-745 | Tazarotene | cream | 1 mg/g | Mayne Pharma | None |
| 0713-0805 | TAZAROTENE | gel | .5 mg/g | Cosette Pharmaceuticals, Inc. | None |
| 45802-436 | TAZAROTENE | gel | .5 mg/g | Padagis Israel Pharmaceuticals Ltd | None |
| 73473-309 | Tazarotene | gel | .5 mg/g | Solaris Pharma Corporation | None |
| 0713-0804 | TAZAROTENE | gel | 1 mg/g | Cosette Pharmaceuticals, Inc. | None |
| 45802-442 | TAZAROTENE | gel | 1 mg/g | Padagis Israel Pharmaceuticals Ltd | None |
| 72162-2202 | TAZAROTENE | gel | 1 mg/g | Bryant Ranch Prepack | None |
| 73473-310 | Tazarotene | gel | 1 mg/g | Solaris Pharma Corporation | None |
| 87143-200 | Trilitas | gel | 1 mg/g | Perfero Pharma, Inc. | None |
Questions
Is tazarotene a controlled substance?
No. Tazarotene is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tazarotene is not on the DEA controlled substances list.
Is tazarotene a narcotic?
No. Tazarotene is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Retinoid.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Tazarotene
- What is Tazarotene used for?FDA label uses
- Generic for FabiorFDA Orange Book
- Generic for AvageFDA Orange Book
- Generic for TazoracFDA Orange Book
- Generic for ArazloFDA Orange Book
- Retinoids listFDA drug class
- NDC 0187-2098Tazarotene NDC record
- NDC 16110-042Tazarotene NDC record
- NDC 16110-833Tazarotene NDC record